Smartphone app oximeter meets hospital standards

March 10, 2014 // By Jean-Pierre Joosting
LionsGate Technologies (LGTmedical), a Vancouver-based social enterprise, has secured its first major financial backers to scale up development of the Phone Oximeter™, an app and medical sensor that turns a non-specialist, community-level health worker's smartphone, tablet computer or laptop into an affordable and simple but sophisticated medical-grade diagnostic tool typically available in the developing world only in some hospitals.

The Phone Oximeter offers hope of preventing thousands of deaths and improving the health of expectant mothers, newborns and children throughout the developing world.

Mr. Irfhan Rajani, CEO of Vancouver-based Coleco Investments, leads a $1 million angel investment in the device, to be matched with a $1 million grant from Grand Challenges Canada — the first such investment under a new $10 million strategic partnership between Grand Challenges Canada and the Department of Foreign Affairs, Trade and Development Canada (DFATD).

"Our Government is promoting innovative approaches to addressing the world's most urgent needs in both global health and international development, including leveraging private sector investment and partnerships that focus on results," said the Hon. Christian Paradis, Canadian Minister of International Development and La Francophonie. "This newest investment is a precise fit with the Prime Minister's global commitment, through the Muskoka Initiative, to improve the health and lives of mothers and children in the world's poorest countries."

The Phone Oximeter™, an app and sensor turns a non-specialist, community-level health worker's smartphone, tablet computer or laptop into an affordable and simple but sophisticated medical-grade diagnostic tool typically available in the developing world only in some hospitals. Source: LionsGate Technologies.